An Overview of the Validation Approach for Moist Heat Sterilization, Part I
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2002
Volume 26
Issue 9
Part I of this article discusses examples for cycle types used in moist heat sterilization, parameter requirements for a standard cycle as defined by pharmacopeias, methods used to design sterilization cycles, and various approaches used to measure the efficiency of the sterilization process.
Articles in this issue
Mixed-Flow Exhaust Technology: A New Approach for Energy Savings and Pollution Abatement
Innovations of Membrane Chromatography for Biomolecular Purification
New Syringe Designs Combine Prefilled Convenience with Safety
A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development
An Overview of the Validation Approach for Moist Heat Sterilization, Part I
Outsourcing Outlook
Spreading of Semisolid Formulations: An Update
Auditing Your Contractor
Attack Mounts on Drug Prices
Recent Videos
Behind the Headlines Episode 14–Investment Trends, Policy Realignments, and Vaccines
Industry Outlook 2025: Political Impacts on Supply Chains
Industry Outlook 2025: Business Viability and Global Collaboration
Industry Outlook 2025: Large Language Models
Drug Digest: Strategic Partnerships
DCAT Week 2025: Quality and Compliance for Animal-derived Products
Industry Outlook 2025: US Political Motivations and Legislative Discussions
Industry Outlook 2025: Consolidating Data and Relaxing Regulations on AI
Industry Outlook 2025: Interesting Relations and Detailed Discussions on Data
International Day of Women and Girls in Science: Fostering STEM Careers for Women
Related Content
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Article
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
